NARF antisense RNA 2 (NARF-AS2)

NARF antisense RNA 2 (NARF-AS2) is likely a member of the natural antisense transcripts (NATs), classified as a long non-coding RNA transcribed in antisense direction to the NARF gene. Antisense RNAs, including NATs, regulate gene expression at multiple levels (replication, transcription, translation), typically by interacting with their sense mRNA partners. These regulatory ncRNAs can modulate expression via chromatin modification, promoter competition, transcriptional interference, or RNA masking mechanisms[1][2][3][4][5]. Antisense RNAs are increasingly recognized for their functions in gene regulation and epigenetic processes and are frequently dysregulated in cancers and some other diseases. However, NARF-AS2 itself is not established as a therapeutic target (like a receptor, enzyme, or transporter) and there is little, if any, evidence for clinically relevant drug interactions or biomarker use. Information specifically about NARF-AS2 remains very limited, and it is likely either a rarely studied, cryptic, or erroneously labeled transcript.

Other names

NARF-AS2